Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Grant or award Chief Executive Officer acquired 26,668 shares (grant or award)
  2. 4 Grant or award Pres., R&D, and CMO acquired 20,001 shares (grant or award)
  3. 4 Open-market sale SVP and General Counsel sold 13,000 shares at an average $282.92 ($3,677,977)
  4. 4 Open-market sale SVP and General Counsel sold 7,000 shares at an average $274.18 ($1,919,231)
  5. 4 Open-market sale Chief Commercial Officer sold 30,000 shares at an average $274.14 ($8,224,073)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 5 Insider Annual Insider Trading Report
  20. 4 Other disposition 10% owner disposed of 824,172 shares (other)

Page 9 of 29 · 564 filings